---
figid: PMC8291015__WJG-27-3748-g001
figtitle: 'Impact of the COVID-19 pandemic on inflammatory bowel disease patients:
  A review of the current evidence'
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Homo sapiens
pmcid: PMC8291015
filename: WJG-27-3748-g001.jpg
figlink: /pmc/articles/PMC8291015/figure/F1/
number: F1
caption: 'Pathogenetic pathway of intestinal severe acute respiratory syndrome coronavirus
  2 infection with proposed inflammatory bowel disease effects. The blue lines represent
  inflammatory bowel disease (IBD)/IBD approach-mediated reduction in either coronavirus
  disease 2019 (COVID-19) acquisition or poor outcomes of it, whereas the red lines
  represent IBD/IBD approach-mediated increase in risk for COVID-19 acquisition or
  poor outcomes. IBD: Inflammatory bowel disease; ADAM17: A disintegrin and metalloproteinase
  17; TNF-α: Tumor necrosis factor-alpha; ACE2: Angiotensin-converting enzyme 2; TMPRSS2:
  Transmembrane protease serine 2; SARS-CoV-2: Severe acute respiratory syndrome coronavirus
  2; IL: Interleukin; G-CSF: Granulocyte-colony stimulating factor; IFN-γ: Interferon-γ.'
papertitle: 'Impact of the COVID-19 pandemic on inflammatory bowel disease patients:
  A review of the current evidence.'
reftext: Marko Kumric, et al. World J Gastroenterol. 2021 Jul 7;27(25):3748-3761.
year: '2021'
doi: 10.3748/wjg.v27.i25.3748
journal_title: World Journal of Gastroenterology
journal_nlm_ta: World J Gastroenterol
publisher_name: Baishideng Publishing Group Inc
keywords: COVID-19 | SARS-CoV-2 | Inflammatory bowel disease | Crohn’s disease | Ulcerative
  colitis
automl_pathway: 0.9336597
figid_alias: PMC8291015__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8291015__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8291015__WJG-27-3748-g001.html
  '@type': Dataset
  description: 'Pathogenetic pathway of intestinal severe acute respiratory syndrome
    coronavirus 2 infection with proposed inflammatory bowel disease effects. The
    blue lines represent inflammatory bowel disease (IBD)/IBD approach-mediated reduction
    in either coronavirus disease 2019 (COVID-19) acquisition or poor outcomes of
    it, whereas the red lines represent IBD/IBD approach-mediated increase in risk
    for COVID-19 acquisition or poor outcomes. IBD: Inflammatory bowel disease; ADAM17:
    A disintegrin and metalloproteinase 17; TNF-α: Tumor necrosis factor-alpha; ACE2:
    Angiotensin-converting enzyme 2; TMPRSS2: Transmembrane protease serine 2; SARS-CoV-2:
    Severe acute respiratory syndrome coronavirus 2; IL: Interleukin; G-CSF: Granulocyte-colony
    stimulating factor; IFN-γ: Interferon-γ.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TMPRSS2
  - ACE2
  - ADAM17
  - TNF
  - CSF3
  - IL22
  - IL21
  - LINC00689
---
